---
title: "High-flyer healthcare stocks: Ten names with strong momentum, weak valuations"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295411523.md"
description: "Wall Street investors are shifting focus to healthcare stocks with strong momentum but weak valuations, seeking refuge from market volatility. Analysts highlight ten companies across biotechnology, pharmaceuticals, and medical equipment sectors that offer high price velocity paired with undervalued metrics. Top picks include Absci Corporation (ABSI), Aclaris Therapeutics (ACRS), and Alumis Inc. (ALMS), all holding A+ momentum grades. This strategy aims to avoid overexposure to highly priced assets by targeting selective screens within the healthcare industry."
datetime: "2026-08-10T13:05:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295411523.md)
  - [en](https://longbridge.com/en/news/295411523.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295411523.md)
---

# High-flyer healthcare stocks: Ten names with strong momentum, weak valuations

Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocity against fundamental underlying valuations. Analysts warn that chasing recent momentum can leave market participants overexposed to highly priced assets, prompti...

### Related Stocks

- [ACRS.US](https://longbridge.com/en/quote/ACRS.US.md)
- [ALMS.US](https://longbridge.com/en/quote/ALMS.US.md)
- [ABSI.US](https://longbridge.com/en/quote/ABSI.US.md)

## Related News & Research

- [Absci (ABSI) Could Be 32% Undervalued Following ABS 201 Data And Earnings](https://longbridge.com/en/news/295686913.md)
- [AbSci: Buy Rating Reaffirmed as ABS-201 Hair-Loss Program Advances; $11 Price Target Maintained](https://longbridge.com/en/news/295652271.md)
- [Visa, Lockheed Martin And A Health Care Stock On CNBC’s ‘Final Trades’](https://longbridge.com/en/news/296127265.md)
- [Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates](https://longbridge.com/en/news/295548881.md)
- [Septerna, Inc. (SEPN) Receives a Rating Update from a Top Analyst](https://longbridge.com/en/news/296029142.md)